US 11,938,120 B1
الصحة - Health
2024
مكتب البراءات الأمريكي - US Patent Office
Venugopala; Katharigatta N. (Al-Ahsa, SA), Deb; Pran Kishore (Ranchi, IN), Pillay; Melendran (Durban, ZA), Chandrashekharappa; Sandeep (Lucknow, IN), Morsy; Mohamed A. (Al-Ahsa, SA), Aldhubiab; Bandar (Al-Ahsa, SA), Attimarad; Mahesh (Al-Ahsa, SA), Nair; Anroop B. (Al-Ahsa, SA), Sreeharsha; Nagaraja (Al-Ahsa, SA), Tratrat; Christophe (Al-Ahsa, SA), Shashikanth; Sheena (Mysore, IN), Uppar; Vijaykumar (Rani Channamma, IN), Padmashali; Basavaraj (Rani Channamma, IN)
Compounds for treating tuberculosis and, particularly, anti-tubercular compounds that are ethyl 2-substitued-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives and their use as anti-tubercular agents are provided.